Перегляд за автором "Litviakov, N.V."
-
Cherdyntseva, N.V.; Litviakov, N.V.; Denisov, E.V.; Gervas, P.A.; Cherdyntsev, E.S.
(Experimental Oncology, 2017)
Each patient has a unique history of cancer ecosystem development, resulting in intratumor heterogeneity. In order to effectively kill the tumor cells by chemotherapy, dynamic monitoring of driver molecular alterations is ...
-
Bychkov, V.A.; Nikitina, E.G.; Ibragimova, M.K.; Kaigorodova, E.V.; Choinzonov, E.L.; Litviakov, N.V.
(Experimental Oncology, 2016)
An etiological role of high risk human papillomavirus (HPV) in the development of cervical cancer has been well established. Hence, attention of researchers has been focused on the role of HPV in pathogenesis of other ...
-
Deryusheva, I.V.; Tsyganov, M.M.; Garbukov, E.Y.; Ibragimova, M.K.; Kzhyshkovska, Ju.G.; Slonimskaya, E.M.; Cherdyntseva, N.V.; Litviakov, N.V.
(Experimental Oncology, 2017)
One of the factors providing the diversity and heterogeneity of malignant tumors, particularly breast cancer, are genetic variations, due to gene polymorphism, and, especially, the phenomenon of loss of heterozygosity ...
-
Vtorushin, S.V.; Khristenko, K.Y.; Zavyalova, M.V.; Perelmuter, V.M.; Litviakov, N.V.; Denisov, E.V.; Dulesova, A.Y.; Cherdyntseva, N.V.
(Experimental Oncology, 2014)
Multi-drug resistance (MDR) is a condition when there is broad cross-resistance of cells to various agents which are different in structure and effect. Modern perceptions on mechanisms of MDR development in malignant tumors ...